Trump, Kushner, Trilogy Evo, Royal Philips N.V. all rip off the American Tax Payer who need our ventilators NOW
US Taxpayers Paid Millions to Design a Low-Cost Ventilator for a Pandemic. Instead, the Company Is Selling Versions of It Overseas.
As coronavirus sweeps the globe, there is not a single Trilogy Evo Universal ventilator — developed with government funds — in the U.S. stockpile. Meanwhile, Royal Philips N.V. has sold higher-priced versions to clients around the world.
ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published.
F^^K Royal Philips N.V.
Five years ago, the U.S. Department of Health and Human Services tried to plug a crucial hole in its preparations for a global pandemic, signing a $13.8 million contract with a Pennsylvania manufacturer to create a low-cost, portable, easy-to-use ventilator that could be stockpiled for emergencies.
This past September, with the design of the new Trilogy Evo Universal finally cleared by the Food and Drug Administration, HHS ordered 10,000 of the ventilators for the Strategic National Stockpile at a cost of $3,280 each. But as the pandemic continues to spread across the globe, there is still not a single Trilogy Evo Universal in the stockpile.
Instead last summer, soon after the FDA’s approval, the Pennsylvania company that designed the device — a subsidiary of the Dutch appliance and technology giant Royal Philips N.V. — began selling two higher-priced commercial versions of the same ventilator around the world.
“We sell to whoever calls,” said a saleswoman at a small medical-supply company on Staten Island that bought 50 Trilogy Evo ventilators from Royal Philips N.V. in early March and last week hiked its online price from $12,495 to $17,154. “We have hundreds of orders to fill. I think America didn’t take this seriously at first, and now everyone’s frantic.”
Philips had agreed to make the Trilogy Evo Universal ventilator “as soon as possible.” However, a Philips spokesman said the company has no plan to even begin production anytime this year.
WHY BECAUSE
Instead, Philips is negotiating with a White House team led by Trump’s son-in-law, Jared Kushner, to build 43,000 more complex and expensive hospital ventilators for Americans stricken by the virus. see Crooks and Liars
THERE ARE NO Ethical guidelines for TRUMP, JARED KUSHNER, or Royal Philips N.V. Trilogy Evo in healthcare!
No there are none.
Class 1 Device Recall Trilogy EVO
Software defect in the Trilogy EVO and Trilogy EVO Universal Ventilator, versions SW 1.00.05, SW 1.01.09.00, SW 1.01.10.00, and SW 1.01.11.00, causing inoperative and loss of all power alarms. This defect causes an incorrect or unexpected result failing requirements TSRS1298 and PRD439. FDA Determined
Selling USA’s medical supply overseas
What Happened To Trump’s Big Ventilator Deal? Depends On Who You Ask
The administration was supposed to announce a deal to produce 80,000 ventilators on Wednesday. Now Trump’s backing off. Trump suddenly halted plans to have GM retool a plant to produce as many as 80,000 ventilators.
Trilogy Evo
The Pennsylvania manufacturer that took OUR TAX MONEY was really just a subsidary of a DUTCH COMPANY Royal Philips NV
@philipshealth @Philips Tell the CEO Franz van Houten of Royal Philips what do you think of this.
@PhilipsHealth
shares his views on how to create an environment where people can succeed and innovation can thrive, read more: their annual report
https://www.philips.com/a-w/about/news/archive/standard/news/press/2020/20200225-philips-publishes-its-annual-report-2019.html
Taxpayers paid millions for a low-cost ventilator for pandemics — which are now being sold overseas
Big Dutch Firm Ripped Off US Taxpayers For Millions On Ventilators
In 2006, the Department of Health and Human Services established a new division, the Biomedical Advanced Research and Development Authority, with a mandate to prepare medical responses to chemical, biological and nuclear attacks as well as infectious diseases.
In its first year in operation, the research agency considered how to expand the number of ventilators. It estimated that an additional 70,000 machines would be required in a moderate influenza pandemic.